{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:58:37Z","timestamp":1792180717743,"version":"4.4.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T00:00:00Z","timestamp":1469664000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Huazhong Univ. Sci. Technol. [Med. Sci.]"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s11596-016-1621-8","type":"journal-article","created":{"date-parts":[[2016,7,27]],"date-time":"2016-07-27T04:10:39Z","timestamp":1469592639000},"page":"534-540","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Efficacy of Bosentan in patients after Fontan procedures: a double-blind, randomized controlled trial"],"prefix":"10.1007","volume":"36","author":[{"given":"Xiao-ke","family":"Shang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-dong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-na","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nian-guo","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,28]]},"reference":[{"issue":"3","key":"1621_CR1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ejcts.2006.11.043","volume":"31","author":"RB Hosein","year":"2007","unstructured":"Hosein RB, Clarke AJ, McGuirk SP, et al. Factors influencing early and late outcome following the Fontan procedure in the current era. The 'Two Commandments'? Eur J Cardiothorac Surg, 2007,31(3):344\u2013352","journal-title":"Eur J Cardiothorac Surg"},{"issue":"1","key":"1621_CR2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1010-7940(03)00186-6","volume":"24","author":"SP McGuirk","year":"2003","unstructured":"McGuirk SP, Winlaw DS, Langley SM, et al. The impact of ventricular morphology on midterm outcome following completion total cavopulmonary connection. Eur J Cardiothorac Surg, 2003,24(1):37\u201346","journal-title":"Eur J Cardiothorac Surg"},{"issue":"6","key":"1621_CR3","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.ejcts.2006.08.025","volume":"30","author":"M Ono","year":"2006","unstructured":"Ono M, Boethig D, Goerler H, et al. Clinical outcome of patients 20 years after Fontan operation\u2014effect of fenestration on late morbidity. Eur J Cardiothorac Surg, 2006,30(6):923\u2013929","journal-title":"Eur J Cardiothorac Surg"},{"issue":"6","key":"1621_CR4","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.athoracsur.2009.07.079","volume":"88","author":"Y d'Udekem","year":"2009","unstructured":"d'Udekem Y, Cheung MM, Setyapranata S, et al. How good is a good Fontan? Quality of life and exercise capacity of Fontans without arrhythmias. Ann Thorac Surg, 2009,88(6):1961\u20131969","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"1621_CR5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jacc.2008.02.081","volume":"52","author":"SM Paridon","year":"2008","unstructured":"Paridon SM, Mitchell PD, Colan SD, et al. A cross-sectional study of exercise performance during the first 2 decades of life after the Fontan operation. J Am Coll Cardiol, 2008,52(2):99\u2013107","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1621_CR6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00246-014-0881-y","volume":"35","author":"M Mori","year":"2014","unstructured":"Mori M, Aguirre AJ, Elder RW, et al. Beyond a broken heart: circulatory dysfunction in the failing Fontan. Pediatr Cardiol, 2014,35(4):569\u2013579","journal-title":"Pediatr Cardiol"},{"issue":"4","key":"1621_CR7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1017\/S1047951109990023","volume":"19","author":"C Ovaert","year":"2009","unstructured":"Ovaert C, Thijs D, Dewolf D, et al. The effect of bosentan in patients with a failing Fontan circulation. Cardiol Young, 2009,19(4):331\u2013339","journal-title":"Cardiol Young"},{"issue":"23","key":"1621_CR8","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1161\/CIRCULATIONAHA.113.008441","volume":"130","author":"A Hebert","year":"2014","unstructured":"Hebert A, Mikkelsen UR, Thilen U, et al. Bosentan improves exercise capacity in adolescents and adults after Fontan operation: the TEMPO (Treatment With Endothelin Receptor Antagonist in Fontan Patients, a Randomized, Placebo-Controlled, Double-Blind Study Measuring Peak Oxygen Consumption) study. Circulation, 2014,130(23):2021\u20132030","journal-title":"Circulation"},{"issue":"17","key":"1621_CR9","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jacc.2009.01.004","volume":"53","author":"VV McLaughlin","year":"2009","unstructured":"McLaughlin VV, Archer SL, Badesch DB, et al. ACCF\/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol, 2009,53(17):1573\u20131619","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"1621_CR10","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s11596-015-1485-3","volume":"35","author":"FF Li","year":"2015","unstructured":"Li FF, Du XL, Chen S. Biventricular repair versus uni-ventricular repair for pulmonary atresia with intact ventrical septum: A systematic review. J Huazhong Univ Sci Technolog Med Sci, 2015,35(5):656\u2013661","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"issue":"1","key":"1621_CR11","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1111\/chd.12189","volume":"10","author":"G Derk","year":"2015","unstructured":"Derk G, Houser L, Miner P, et al. Efficacy of endothelin blockade in adults with Fontan physiology. Congenit Heart Dis, 2015,10(1):E11\u201316","journal-title":"Congenit Heart Dis"},{"issue":"3","key":"1621_CR12","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1747-0803.2012.00635.x","volume":"7","author":"SE Bowater","year":"2012","unstructured":"Bowater SE, Weaver RA, Thorne SA, et al. The safety and effects of bosentan in patients with a Fontan circulation. Congenit Heart Dis, 2012,7(3):243\u2013249","journal-title":"Congenit Heart Dis"},{"issue":"6","key":"1621_CR13","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/eurjhf\/hft017","volume":"15","author":"MJ Schuuring","year":"2013","unstructured":"Schuuring MJ, Vis JC, van Dijk AP, et al. Impact of bosentan on exercise capacity in adults after the Fontan procedure: a randomized controlled trial. Eur J Heart Fail, 2013,15(6):690\u2013698","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"1621_CR14","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.crad.2015.02.011","volume":"70","author":"G Lewis","year":"2015","unstructured":"Lewis G, Thorne S, Clift P, et al. Cross-sectional imaging of the Fontan circuit in adult congenital heart disease. Clin Radiol, 2015,70(6):667\u2013675","journal-title":"Clin Radiol"},{"issue":"4","key":"1621_CR15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1469-7580.2002.00097.x","volume":"201","author":"AA Hislop","year":"2002","unstructured":"Hislop AA. Airway and blood vessel interaction during lung development. J Anat, 2002,201(4):325\u2013334","journal-title":"J Anat"},{"issue":"1","key":"1621_CR16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1745-7270.2006.00123.x","volume":"38","author":"YL Jiang","year":"2006","unstructured":"Jiang YL, Dai AG, Li QF, et al. Transforming growth factor-beta1 induces transdifferentiation of fibroblasts into myofibroblasts in hypoxic pulmonary vascular remodeling. Acta Biochim Biophys Sin (Shanghai), 2006,38(1):29\u201336","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"1","key":"1621_CR17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1203\/01.PDR.0000163614.20031.C5","volume":"58","author":"A Hara","year":"2005","unstructured":"Hara A, Chapin CJ, Ertsey R, et al. Changes in fetal lung distension alter expression of vascular endothelial growth factor and its isoforms in developing rat lung. Pediatr Res, 2005,58(1):30\u201337","journal-title":"Pediatr Res"},{"issue":"4","key":"1621_CR18","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1086\/674767","volume":"3","author":"DG Papamatheakis","year":"2013","unstructured":"Papamatheakis DG, Chundu M, Blood AB, et al. Prenatal programming of pulmonary hypertension induced by chronic hypoxia or ductal ligation in sheep. Pulm Circ, 2013,3(4):757\u2013780","journal-title":"Pulm Circ"},{"issue":"3","key":"1621_CR19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/icvts\/ivs150","volume":"15","author":"EW Peng","year":"2012","unstructured":"Peng EW, Spooner R, Young D, et al. Acute B-type natriuretic peptide response and early postoperative right ventricular physiology following tetralogy of Fallot's repair. Interact Cardiovasc Thorac Surg, 2012,15(3):335\u2013339","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"4","key":"1621_CR20","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.cct.2011.04.001","volume":"32","author":"MJ Schuuring","year":"2011","unstructured":"Schuuring MJ, Vis JC, Bouma BJ, et al. Rationale and design of a trial on the role of bosentan in Fontan patients: improvement of exercise capacity? Contemp Clin Trials, 2011,32(4):586\u2013591","journal-title":"Contemp Clin Trials"},{"issue":"3","key":"1621_CR21","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1113\/expphysiol.2007.040469","volume":"93","author":"L Ray","year":"2008","unstructured":"Ray L, Mathieu M, Jespers P, et al. Early increase in pulmonary vascular reactivity with overexpression of endothelin-1 and vascular endothelial growth factor in canine experimental heart failure. Exp Physiol, 2008,93(3):434\u2013442","journal-title":"Exp Physiol"},{"issue":"24","key":"1621_CR22","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1136\/hrt.2009.170241","volume":"95","author":"M Sugimoto","year":"2009","unstructured":"Sugimoto M, Masutani S, Seki M, et al. High serum levels of procollagen type III N-terminal amino peptide in patients with congenital heart disease. Heart, 2009,95 (24):2023\u20132028","journal-title":"Heart"},{"issue":"9","key":"1621_CR23","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/jama.2013.1363","volume":"309","author":"A Gulati","year":"2013","unstructured":"Gulati A, Jabbour A, Ismail TF, et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA, 2013,309(9):896\u2013908","journal-title":"JAMA"},{"issue":"2","key":"1621_CR24","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3109\/0886022X.2013.836935","volume":"36","author":"D Rebic","year":"2014","unstructured":"Rebic D, Rasic S, Rebic V. Influence of endothelin-1 and nitric oxide on left ventricular remodelling in patients on peritoneal dialysis. Ren Fail, 2014,36(2):232\u2013236","journal-title":"Ren Fail"},{"issue":"1","key":"1621_CR25","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijcard.2011.02.021","volume":"159","author":"H Ishida","year":"2012","unstructured":"Ishida H, Kogaki S, Ichimori H, et al. Overexpression of endothelin-1 and endothelin receptors in the pulmonary arteries of failed Fontan patients. Int J Cardiol, 2012,159(1):34\u201339","journal-title":"Int J Cardiol"},{"issue":"2","key":"1621_CR26","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1161\/01.CIR.103.2.314","volume":"103","author":"JF Jasmin","year":"2001","unstructured":"Jasmin JF, Lucas M, Cernacek P, et al. Effectiveness of a nonselective ET(A\/B) and a selective ET(A) antagonist in rats with monocrotaline-induced pulmonary hypertension. Circulation, 2001,103(2):314\u2013318","journal-title":"Circulation"},{"issue":"4","key":"1621_CR27","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1378\/chest.129.4.1009","volume":"129","author":"RL Benza","year":"2006","unstructured":"Benza RL, Rayburn BK, Tallaj JA, et al. Efficacy of bosentan in a small cohort of adult patients with pulmonary arterial hypertension related to congenital heart disease. Chest, 2006,129(4):1009\u20131015","journal-title":"Chest"},{"issue":"3","key":"1621_CR28","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ijcard.2009.04.037","volume":"144","author":"RM Berger","year":"2010","unstructured":"Berger RM, Beghetti M, Galie N, et al. Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo-controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: a subgroup analysis. Int J Cardiol, 2010,144(3):373\u2013378","journal-title":"Int J Cardiol"}],"container-title":["Journal of Huazhong University of Science and Technology [Medical Sciences]"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-016-1621-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11596-016-1621-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-016-1621-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T19:15:58Z","timestamp":1498331758000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11596-016-1621-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,28]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["1621"],"URL":"https:\/\/doi.org\/10.1007\/s11596-016-1621-8","relation":{},"ISSN":["1672-0733","1993-1352"],"issn-type":[{"value":"1672-0733","type":"print"},{"value":"1993-1352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,28]]}}}